Back to KRYS
Frazier Life Sciences Management, L.P. → KRYS
Frazier Life Sciences Management, L.P. KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
4
Latest value
$130.1M
Q3 2026
Peak value
$178.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $120.4M |
| Q1 2026 | $124.3M |
| Q2 2026 | $178.9M |
| Q3 2026 | $130.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $130.1M | 391.3K | — | — |
| Q2 2026 | $178.9M | 481.3K | — | — |
| Q1 2026 | $124.3M | 481.3K | — | — |
| Q4 2025 | $120.4M | 488.5K | — | — |
Other funds holding KRYS
$1.2B
$1.1B
$1.1B
$960.7M
$857.3M
$814.4M
$774.3M